Top 100 Contractors in NAICS 32541: Pharmaceutical and Medicine Manufacturing, FY2021
Parent companies by net contract obligations Oct 1, 2020 – Sep 30, 2021 Code page on GovTribe
The top 10 won 95% of FY2021 NAICS 32541 contract dollars
Ranking facts
- Contract obligations
- $55,780,216,011 Net of deobligations, by contracts coded NAICS 32541 or a code under it
- Contractors
- 726 Parent companies with an obligation
- Largest contractor
- Pfizer Inc. $23.1 billion, 40.7% of obligations
- Data as of
Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV
Full ranking
| Rank | Contractor | Net obligations | Share | Trend |
|---|---|---|---|---|
| 1 | $23,135,362,935 | |||
| 2 | $11,700,888,945 | |||
| 3 | $7,363,802,587 | |||
| 4 | $5,565,148,165 | |||
| 5 |
ELI Lilly and Company
Top agencies
|
$1,913,730,016 | ||
| 6 | $1,663,247,245 | |||
| 7 |
Merck & Co. Inc.
|
$1,313,638,023 | ||
| 8 | $515,938,382 | |||
| 9 |
Glaxosmithkline LLC
|
$287,673,486 | ||
| 10 | $257,359,270 | |||
| 11 |
Astrazeneca PLC
|
$214,573,577 | ||
| 12 | $162,082,167 | |||
| 13 | $95,497,600 | |||
| 14 | $86,190,090 | |||
| 15 | $79,896,354 | |||
| 16 | $76,445,797 | |||
| 17 | $70,002,309 | |||
| 18 | $69,300,000 | |||
| 19 | $63,612,248 | |||
| 20 | $61,567,403 | |||
| 21 | $54,227,528 | |||
| 22 | $53,538,814 | |||
| 23 | $50,027,140 | |||
| 24 | $49,650,000 | |||
| 25 | $40,121,477 | |||
| 26 |
Teva Pharmaceutical Industries Ltd.
Top agencies
|
$39,889,900 | ||
| 27 |
Grifols Diagnostic Solutions Inc.
|
$39,829,252 | ||
| 28 | $34,953,404 | |||
| 29 |
Seqirus USA Inc.
|
$28,397,992 | ||
| 30 | $25,322,914 | |||
| 31 |
Compagnie Merieux Alliance
|
$24,522,725 | ||
| 32 |
Roche Holding AG
|
$24,424,137 | ||
| 33 | $23,855,151 | |||
| 34 |
Government of Canada
Top agencies
|
$22,980,675 | ||
| 35 | $22,501,800 | |||
| 36 | $21,000,000 | |||
| 37 |
Boehringer Ingelheim Corporation
|
$19,938,662 | ||
| 38 | $19,573,316 | |||
| 39 | $18,935,188 | |||
| 40 | $15,295,475 | |||
| 41 |
Baxter International Inc.
|
$14,652,640 | ||
| 42 | $13,743,102 | |||
| 43 | $13,476,004 | |||
| 44 | $13,251,536 | |||
| 45 | $13,227,522 | |||
| 46 | $13,048,850 | |||
| 47 |
Celltrion USA Inc.
Top agencies
|
$12,528,000 | ||
| 48 | $12,038,046 | |||
| 49 | $10,528,442 | |||
| 50 | $10,000,000 | |||
| 51 | $9,885,816 | |||
| 52 | $9,248,182 | |||
| 53 |
Fresenius Kabi LLC
|
$8,344,855 | ||
| 54 |
Mylan Pharmaceuticals Inc.
Top agencies
|
$8,250,000 | ||
| 55 | $8,010,031 | |||
| 56 | $7,882,656 | |||
| 57 | $7,541,658 | |||
| 58 |
Novartis AG
|
$7,507,207 | ||
| 59 | $6,932,000 | |||
| 60 |
Catalent Indiana LLC
Top agencies
|
$6,640,000 | ||
| 61 | $6,366,653 | |||
| 62 | $6,253,710 | |||
| 63 |
Melling LLC
Top agencies
|
$5,520,523 | ||
| 64 |
Omnipoynt, LLC
Top agencies
|
$5,330,074 | ||
| 65 | $4,928,795 | |||
| 66 | $4,626,936 | |||
| 67 |
Accredo Health Group Inc.
|
$4,617,788 | ||
| 68 |
Kaleo, Inc.
Top agencies
|
$4,500,000 | ||
| 69 |
Immucor Inc.
|
$4,163,649 | ||
| 70 |
Heyl Chemisch-Pharmazeutische Fabrik GMBH & Co. KG
|
$4,078,224 | ||
| 71 |
Johnson & Johnson
|
$4,078,207 | ||
| 72 | $3,741,709 | |||
| 73 | $3,396,137 | |||
| 74 | $3,200,000 | |||
| 75 | $3,193,438 | |||
| 76 |
Biogenesis Bago S.A.
Top agencies
|
$3,162,500 | ||
| 77 | $3,160,680 | |||
| 78 | $3,098,443 | |||
| 79 | $3,047,028 | |||
| 80 | $2,971,153 | |||
| 81 |
Bracco SPA
|
$2,932,777 | ||
| 82 | $2,929,397 | |||
| 83 |
Stratatech Corporation
|
$2,552,549 | ||
| 84 |
Albany Molecular Research Inc.
|
$2,538,272 | ||
| 85 | $2,405,848 | |||
| 86 |
Akorn, Inc.
Top agencies
|
$2,400,193 | ||
| 87 | $2,334,244 | |||
| 88 |
Sysmex Corporation
|
$2,269,811 | ||
| 89 |
Schaaf Drugs, LLC
Top agencies
|
$2,266,735 | ||
| 90 | $2,250,055 | |||
| 91 |
Avkare LLC
|
$2,230,760 | ||
| 92 | $2,057,054 | |||
| 93 | $2,015,908 | |||
| 94 |
Luminostics Inc.
Top agencies
|
$2,000,000 | ||
| 95 |
Greer Laboratories Inc.
Top agencies
|
$1,904,073 | ||
| 96 |
Avista Pharma Solutions Inc.
Top agencies
|
$1,837,747 | ||
| 97 | $1,749,853 | |||
| 98 | $1,744,186 | |||
| 99 | $1,727,716 | |||
| 100 | $1,682,879 |
Show 75 more
100 of 726 contractors listed here. See the rest on GovTribe.
Rankings for the codes under NAICS 32541
| Code | Net obligations | Largest contractor |
|---|---|---|
| 325414 Biological Product (except Diagnostic) Manufacturing | $29,614,835,947 | Pfizer Inc. |
| 325412 Pharmaceutical Preparation Manufacturing | $20,610,456,989 | Mckesson Corporation |
| 325411 Medicinal and Botanical Manufacturing | $3,543,103,624 | Mckesson Corporation |
| 325413 In-Vitro Diagnostic Substance Manufacturing | $2,011,819,451 | Abbott Laboratories |
How this ranking works
- Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
- Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $56.8 billion obligated before deobligations, so they never pass 100%.
- Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
- Fiscal year 2021 ran Oct 1, 2020 – Sep 30, 2021. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
- Rank changes compare with FY2020. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
- Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2020 takes the color of the rank change beside it.
- Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.
Quick answers
Who were the top 10 NAICS 32541 contractors in FY2021?
1. Pfizer Inc. ($23.1B), 2. Mckesson Corporation ($11.7B), 3. Modernatx Inc. ($7.36B), 4. Regeneron Pharmaceuticals Inc. ($5.57B), 5. ELI Lilly and Company ($1.91B), 6. Abbott Laboratories ($1.66B), 7. Merck & Co. Inc. ($1.31B), 8. Cencora, Inc. ($516M), 9. Glaxosmithkline LLC ($288M), 10. Emergent Biosolutions Inc. ($257M).
On GovTribe
Research every contractor on this list
- Every contract, task order and IDV they hold
- Their subsidiaries, teammates and competitors
- Open opportunities they're positioned for
- Alerts when they win new work